2024
In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis
Aggarwal A, Jang S, Vardhan S, Webber F, Alam M, Vardhan M, Lancaster G, Ahmad Y, Vora A, Zarich S, Inglessis-Azuaje I, Elmariah S, Forrest J, Davila C. In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis. Structural Heart 2024, 100327. DOI: 10.1016/j.shj.2024.100327.Peer-Reviewed Original ResearchSurgical aortic valve replacementTranscatheter aortic valve replacementAortic valve replacementTranscatheter aortic valve replacement groupValve replacementIn-hospital mortalityHepatorenal syndromeReadmission ratesCardiogenic shockLiver cirrhosisVascular complicationsIn-hospitalOutcomes of transcatheter aortic valve replacementSurgical risk prediction modelsSurgical aortic valve replacement groupAssociated with significantly lower ratesRates of in-hospital mortalityLimited contemporary dataIn-hospital outcomesSignificantly lower ratesNationwide Readmissions DatabaseCardiac surgeryPeriprocedural morbidityTherapeutic optionsClinical characteristics
2023
TCT-67 Comparison of In-Hospital Outcomes and 30-Day Readmission Rates Between Patients Who Underwent TAVR Versus SAVR for Aortic Stenosis in Liver Cirrhosis: A Propensity-Matched Analysis
Aggarwal A, Jang S, Vardhan S, Webber F, Lancaster G, Zarich S, Vora A, Elmariah S, Davila C. TCT-67 Comparison of In-Hospital Outcomes and 30-Day Readmission Rates Between Patients Who Underwent TAVR Versus SAVR for Aortic Stenosis in Liver Cirrhosis: A Propensity-Matched Analysis. Journal Of The American College Of Cardiology 2023, 82: b27. DOI: 10.1016/j.jacc.2023.09.072.Peer-Reviewed Original ResearchCOMPARISON OF IN - HOSPITAL OUTCOMES AND THIRTY - DAY READMISSION RATES BETWEEN PATIENTS WHO UNDERWENT TAVR VERSUS SAVR FOR AORTIC STENOSIS IN LIVER CIRRHOSIS: RESULTS FROM NATIONWIDE READMISSIONS DATABASE
Aggarwal A, Jang S, Webber F, Shkolnik E, Pinto E, Lancaster G, Zarich S. COMPARISON OF IN - HOSPITAL OUTCOMES AND THIRTY - DAY READMISSION RATES BETWEEN PATIENTS WHO UNDERWENT TAVR VERSUS SAVR FOR AORTIC STENOSIS IN LIVER CIRRHOSIS: RESULTS FROM NATIONWIDE READMISSIONS DATABASE. Journal Of The American College Of Cardiology 2023, 81: 1020. DOI: 10.1016/s0735-1097(23)01464-x.Peer-Reviewed Original ResearchASSOCIATION OF INVASIVE HEMODYNAMIC MONITORING IN CARDIOGENIC SHOCK WITH EARLY MORTALITY, READMISSION RATES AND MECHANICAL CIRCULATORY SUPPORT USE: PROPENSITY SCORE MATCHING ANALYSIS FROM NATIONWIDE READMISSIONS DATABASE
Webber F, Jang S, Zarich S, Kittleson M. ASSOCIATION OF INVASIVE HEMODYNAMIC MONITORING IN CARDIOGENIC SHOCK WITH EARLY MORTALITY, READMISSION RATES AND MECHANICAL CIRCULATORY SUPPORT USE: PROPENSITY SCORE MATCHING ANALYSIS FROM NATIONWIDE READMISSIONS DATABASE. Journal Of The American College Of Cardiology 2023, 81: 372. DOI: 10.1016/s0735-1097(23)00816-1.Peer-Reviewed Original Research
2021
Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis
Jang S, Yeo I, Jonas C, Goyal P, Cheung J, Feldman D, McCullough S, Krishnan U, Narotsky D, Singh H, Minutello R, Bergman G, Wong S, Kim L. Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis. Journal Of Clinical Medicine 2021, 10: 3701. PMID: 34441995, PMCID: PMC8397058, DOI: 10.3390/jcm10163701.Peer-Reviewed Original ResearchTTS patientsReadmission ratesA Nationwide Readmissions Database AnalysisNationwide Readmissions Database AnalysisThirty-day readmission ratesNon-cardiac causesNationwide Readmissions DatabasePresence of malignancyIndex hospitalizationTakotsubo syndromeOverall burdenCommon causePatientsReadmissionMalignancyDatabase analysisHospitalizationCauseComorbiditiesSyndrome
2020
Associations Between Hospital Length of Stay, 30‐Day Readmission, and Costs in ST‐Segment–Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis
Jang S, Yeo I, Feldman D, Cheung J, Minutello R, Singh H, Bergman G, Wong S, Kim L. Associations Between Hospital Length of Stay, 30‐Day Readmission, and Costs in ST‐Segment–Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis. Journal Of The American Heart Association 2020, 9: e015503. PMID: 32468933, PMCID: PMC7428974, DOI: 10.1161/jaha.119.015503.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnterior Wall Myocardial InfarctionCost SavingsCost-Benefit AnalysisDatabases, FactualFemaleHospital CostsHumansLength of StayMaleMiddle AgedPatient ReadmissionPercutaneous Coronary InterventionRecurrenceRisk FactorsST Elevation Myocardial InfarctionTime FactorsTreatment OutcomeUnited StatesConceptsST-segment elevation myocardial infarctionPrimary percutaneous coronary interventionPercutaneous coronary interventionCoronary interventionSTEMI groupShorter LOSReadmission ratesMyocardial infarctionInfarct locationNationwide Readmissions Database AnalysisNationwide Readmissions DatabaseElevation myocardial infarctionEnormous economic burdenBackground ReadmissionLOS cohortReadmission mortalitySTEMI cohortSTEMI hospitalizationsUS healthcare systemHospital stayHospital lengthLonger LOSReadmissionEconomic burdenPatients